Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -100.00% vs 422.39% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -100.00% vs -84.62% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -2.90% vs 23.50% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is -23.81% vs 24.55% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 19.98% vs 11.12% in Mar 2025
Compare Balance Sheet Results of Anuh Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
50.11
12.84
37.27
290.26%
Share Warrants & Outstandings
Total Reserve
302.11
132.36
169.75
128.25%
Shareholder's Funds
352.22
145.19
207.03
142.59%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
29.48
-29.48
-100.00%
Secured Loans
0.00
29.48
-29.48
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-3.86
0.53
-4.39
-828.30%
Other Long Term Liabilities
0.00
0.13
-0.13
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.14
0.46
1.68
365.22%
Total Non-Current Liabilities
-1.72
30.60
-32.32
-105.62%
Current Liabilities
Trade Payables
187.66
5.97
181.69
3,043.38%
Other Current Liabilities
15.08
1.43
13.65
954.55%
Short Term Borrowings
0.00
8.76
-8.76
-100.00%
Short Term Provisions
0.27
0.03
0.24
800.00%
Total Current Liabilities
203.00
16.18
186.82
1,154.64%
Total Liabilities
553.51
191.98
361.53
188.32%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
120.79
90.15
30.64
33.99%
Less: Accumulated Depreciation
72.26
32.20
40.06
124.41%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
48.52
57.95
-9.43
-16.27%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
8.34
-8.34
-100.00%
Intangible assets under development
0.00
0.43
-0.43
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
39.58
0.16
39.42
24,637.50%
Long Term Loans & Advances
0.69
1.55
-0.86
-55.48%
Other Non Current Assets
5.30
8.96
-3.66
-40.85%
Total Non-Current Assets
102.19
114.45
-12.26
-10.71%
Current Assets Loans & Advances
Current Investments
44.86
18.26
26.60
145.67%
Inventories
147.75
22.02
125.73
570.98%
Sundry Debtors
238.63
22.27
216.36
971.53%
Cash and Bank
8.30
9.99
-1.69
-16.92%
Other Current Assets
10.33
1.50
8.83
588.67%
Short Term Loans and Advances
1.44
3.49
-2.05
-58.74%
Total Current Assets
451.32
77.53
373.79
482.12%
Net Current Assets (Including Current Investments)
248.31
61.35
186.96
304.74%
Total Current Assets Excluding Current Investments
406.46
59.27
347.19
585.78%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
553.51
191.98
361.53
188.32%
Contingent Liabilities
7.45
5.21
2.24
42.99%
Total Debt
0.00
38.25
-38.25
-100.00%
Book Value per share (adjusted)
35.14
113.10
-77.96
-68.93%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 422.39% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs -84.62% in Mar 2025
Annual - Fixed Assets
Fixed Assets 48.52 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.90% vs 23.50% in Mar 2025
Annual - Investments
Investments 39.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -23.81% vs 24.55% in Mar 2025
Annual - Current Assets
Current Assets 451.32 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.98% vs 11.12% in Mar 2025






